CHRM1 and malignant colon neoplasm: Second, persistent over-expression of M1R in metastatic cells compared to a normal colon suggests that M1R is accessible for targeting to attenuate the proliferation of metastatic colon cancer cells, thereby potentially blocking the expansion and, more intriguingly, promoting the regression of colon cancer metastases.